ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease. [electronic resource]
Producer: 20180831Description: 265-276 p. digitalISSN:- 1873-2747
- Alzheimer Disease -- drug therapy
- Amyloid beta-Peptides
- Animals
- Anxiety -- drug therapy
- Corticosterone -- metabolism
- Depression -- drug therapy
- Disease Models, Animal
- Glyburide -- pharmacology
- Hypothalamo-Hypophyseal System -- drug effects
- KATP Channels -- antagonists & inhibitors
- Nootropic Agents -- pharmacology
- Peptide Fragments
- Pituitary-Adrenal System -- drug effects
- Potassium Channel Blockers -- pharmacology
- Rats, Wistar
- Stress, Psychological -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.